Cargando…
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded considerably over the last 10 years with the approval of multiple new disease-modifying therapies (DMTs), and others in late-stage clinical development. All DMTs for RMS are believed to reduce central nervous system...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688209/ https://www.ncbi.nlm.nih.gov/pubmed/28879412 http://dx.doi.org/10.1007/s00415-017-8594-9 |